🇺🇸 FDA
Patent

US 10492518

Blood lipid-lowering composition, method for preparing the same and use thereof

granted A61KA61K2236/15A61K36/286

Quick answer

US patent 10492518 (Blood lipid-lowering composition, method for preparing the same and use thereof) held by INFINITUS (CHINA) COMPANY LTD. expires Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
INFINITUS (CHINA) COMPANY LTD.
Grant date
Tue Dec 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K2236/15, A61K36/286, A61K36/30, A61K36/31